Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

The type 5 metabotropic glutamate receptor, mGlu5, has been proposed as a potential therapeutic target for the treatment of several neurodegenerative diseases. In preclinical neurodegenerative disease models, novel allosteric modulators have been shown to improve cognitive performance and reduce dis...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Rebecca F. Budgett, Geor Bakker, Eugenia Sergeev, Kirstie A. Bennett, Sophie J. Bradley
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2022-05-01
Серии:Frontiers in Pharmacology
Предметы:
GPCR
Alzheimer’s disease
neurodegenerative disease
neuroinflammation
G protein coupled receptors
drug discovery
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fphar.2022.893422/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы